Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Infection and Immunity|April 26, 2017
Bacillus anthracis Edema Toxin Increases Fractional Free Water and Sodium Reabsorption in an Isolated Perfused Rat Kidney ModelDharmvir S Jaswal, Xizhong Cui, Parizad Torabi-Parizi, et al.
Critical Care Medicine|February 15, 2011
The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studiesYan Li, Jun-Feng Sun, Xizhong Cui, et al.
The Journal of Trauma|January 14, 2010
SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in miceJunwu Su, Xizhong Cui, Yan Li, et al.
Critical Care Medicine|February 27, 2009
Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in ratsYan Li, Xizhong Cui, Junwu Su, et al.
Scientific Reports|April 12, 2025
Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant modelsColleen S Curran, Xizhong Cui, Yan Li, et al.
Shock (Augusta, Ga.)|February 19, 2005
Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogsJonathan Sevransky, R William Vandivier, Eric Gerstenberger, et al.
Intensive Care Medicine|September 17, 2011
The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis modelPing Qiu, Yan Li, Yi Ding, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 12, 2015
Bacillus anthracis edema but not lethal toxin challenge in rats is associated with depressed myocardial function in hearts isolated and tested in a Langendorff systemYan Li, Mones Abu-Asab, Junwu Su, et al.
The Journal of Infectious Diseases|January 7, 2012
Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in caninesAmisha V Barochia, Xizhong Cui, Junfeng Sun, et al.
Critical Care Medicine|February 22, 2011
Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in miceLaith Altaweel, Zhaochun Chen, Mahtab Moayeri, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Infection and Immunity|April 26, 2017
Bacillus anthracis Edema Toxin Increases Fractional Free Water and Sodium Reabsorption in an Isolated Perfused Rat Kidney ModelDharmvir S Jaswal, Xizhong Cui, Parizad Torabi-Parizi, et al.
Critical Care Medicine|February 15, 2011
The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studiesYan Li, Jun-Feng Sun, Xizhong Cui, et al.
The Journal of Trauma|January 14, 2010
SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in miceJunwu Su, Xizhong Cui, Yan Li, et al.
Critical Care Medicine|February 27, 2009
Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in ratsYan Li, Xizhong Cui, Junwu Su, et al.
Scientific Reports|April 12, 2025
Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant modelsColleen S Curran, Xizhong Cui, Yan Li, et al.
Shock (Augusta, Ga.)|February 19, 2005
Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogsJonathan Sevransky, R William Vandivier, Eric Gerstenberger, et al.
Intensive Care Medicine|September 17, 2011
The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis modelPing Qiu, Yan Li, Yi Ding, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 12, 2015
Bacillus anthracis edema but not lethal toxin challenge in rats is associated with depressed myocardial function in hearts isolated and tested in a Langendorff systemYan Li, Mones Abu-Asab, Junwu Su, et al.
The Journal of Infectious Diseases|January 7, 2012
Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in caninesAmisha V Barochia, Xizhong Cui, Junfeng Sun, et al.
Critical Care Medicine|February 22, 2011
Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in miceLaith Altaweel, Zhaochun Chen, Mahtab Moayeri, et al.
Pageof 13